Evidence map›Paper›PMID 25975821›Full record

ArticleBMC genomics2015

Microarray transcriptional profiling of Arctic Mesorhizobium strain N33 at low temperature provides insights into cold adaption strategies.

Abdollah-Fardin Ghobakhlou, Anne Johnston, Linda Harris, Hani Antoun, Serge Laberge

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Adaptive Evolution ofMicroorganisms · 2025
    Article
  2. Review
  3. Comparative genomics of the extremophileFrontiers in fungal biology · 2024
    Article
  4. Review
  5. Review
  6. Regulated strategies of cold-adapted microorganisms in response to cold: a review.Environmental science and pollution research international · 2021
    Review
  7. Article
  8. Review
  9. Reporting Key Features in Cold-Adapted Bacteria.Life (Basel, Switzerland) · 2018
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Abdollah-Fardin GhobakhlouGraduate Programs in Agri-Food Microbiology, Faculty of Agriculture and Food Sciences, Laval University, Quebec City, Quebec, G1V 0A6, Canada. Ghobakhloufa@gmail.com.
Anne JohnstonEastern Cereal & Oilseed Research Centre, Agriculture and Agri-Food Canada, Ottawa, Ontario, K1A 0C6, Canada. Anne.Johnston@agr.gc.ca.
Linda HarrisEastern Cereal & Oilseed Research Centre, Agriculture and Agri-Food Canada, Ottawa, Ontario, K1A 0C6, Canada. Linda.Harris@agr.gc.ca.
Hani AntounDepartment of Soils and Agri-Food Engineering, Laval University, Quebec City, Quebec, G1V 0A6, Canada. Hani.antoun.1@ulaval.ca.
Serge LabergeSoils and Crops Research Development Center, Agriculture and Agri-Food Canada, Quebec City, Quebec, G1V 2 J3, Canada. Laberge.r@videotron.ca.
Agriculture and Agri-Food Canada · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArctic Mesorhizobium strain N33 was isolated from nodules of the legume Oxytropis arctobia in Canada's eastern Arctic. This symbiotic bacterium can grow at temperatures ranging from 0 to 30 °C, fix nitrogen at 10 °C, and is one of the best known cold-adapted rhizobia. Despite the economic potential of this bacterium for northern regions, the key molecular mechanisms of its cold adaptation remain poorly understood.

resultsUsing a microarray printed with 5760 Arctic Mesorhizobium genomic clones, we performed a partial transcriptome analysis of strain N33 grown under eight different temperature conditions, including both sustained and transient cold treatments, compared with cells grown at room temperature. Cells treated under constant (4 and 10 °C) low temperatures expressed a prominent number of induced genes distinct from cells treated to short-term cold-exposure (<60 min), but exhibited an intermediate expression profile when exposed to a prolonged cold exposure (240 min). The most prominent up-regulated genes encode proteins involved in metabolite transport, transcription regulation, protein turnover, oxidoreductase activity, cryoprotection (mannitol, polyamines), fatty acid metabolism, and membrane fluidity. The main categories of genes affected in N33 during cold treatment are sugar transport and protein translocation, lipid biosynthesis, and NADH oxidoreductase (quinone) activity. Some genes were significantly down-regulated and classified in secretion, energy production and conversion, amino acid transport, cell motility, cell envelope and outer membrane biogenesis functions. This might suggest growth cessation or reduction, which is an important strategy to adjust cellular function and save energy under cold stress conditions.

conclusionOur analysis revealed a complex series of changes associated with cold exposure adaptation and constant growth at low temperatures. Moreover, it highlighted some of the strategies and different physiological states that Mesorhizobium strain N33 has developed to adapt to the cold environment of the Canadian high Arctic and has revealed candidate genes potentially involved in cold adaptation.

Indexed as

Cold TemperatureGene Expression ProfilingOligonucleotide Array Sequence AnalysisAdaptation, PhysiologicalBacterial ProteinsBiofilmsBiological TransportCarbohydrate MetabolismCell MembraneCluster AnalysisDNA RepairDNA ReplicationEnergy MetabolismGenomicsLipid MetabolismMesorhizobiumBacterial ProteinsMolecular ChaperonesNucleotidesReactive Oxygen SpeciesTranscription Factors

Identifiers

PMID25975821
PMCPMC4432818
OpenAlexW1515466673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.